However, with their rise in usage, concerns have emerged about potential side effects, including vision issues
HPLC-verified purity, third-party tested, research-grade quality
We are excited to help pave the way, providing evidence of how these medications may impact our patients ocular health. Advertisement Advertisement New insights on effectiveness in patients previously treated with other anti-VEGF drugs CFH gene triggers the eye disease in white patients but not Black patients A primer on sustained release options Study explores association between sleep aid and eye disease Early data show risk is 73% higher in patients with lupus, 40% higher in patients with rheumatoid arthritis Switching medications may decrease treatment burden and macular fluid Why retina specialists should get comfortable with this imaging tool Large retrospective analysis may prompt prospective studies
Today 6 , 408410 (2000)
Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, et al